Screener
Avalo Therapeutics AVTX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Avalo Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001534120-26-000049
FAQ
- What is Avalo Therapeutics's total assets?
- Avalo Therapeutics (AVTX) reported total assets of $490.78M in Q2 2026.
- How has Avalo Therapeutics's total assets changed year-over-year?
- Avalo Therapeutics's total assets increased by 287.7% year-over-year, from $126.58M to $490.78M.
- What is the long-term trend for Avalo Therapeutics's total assets?
- Over 5 years (2020 to 2025), Avalo Therapeutics's total assets has grown at a 21.6% compound annual growth rate (CAGR), from $43.76M to $116.46M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Avalo Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude